tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NTBL Stock Latest News

Notable Labs Files for Bankruptcy and Leadership Change
Company AnnouncementsNotable Labs Files for Bankruptcy and Leadership Change
1y ago
8K
NTBL
Vascular Biogenics Inc trading halted, news pending
PremiumThe Fly
Vascular Biogenics Inc trading halted, news pending
1y ago
NTBL
Notable Labs downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
Notable Labs downgraded to Market Perform from Outperform at JMP Securities
1y ago
NTBL
Notable Labs Appoints Kaile Zagger as Interim CEO
PremiumCompany Announcements
Notable Labs Appoints Kaile Zagger as Interim CEO
1y ago
8K
NTBL
Notable Labs Management Shift with New Interim CEO
PremiumCompany Announcements
Notable Labs Management Shift with New Interim CEO
1y ago
8K
NTBL
Notable Labs CEO Thomas Bock resigns
PremiumThe FlyNotable Labs CEO Thomas Bock resigns
1y ago
NTBL
Notable Labs Advances with Phase 2 Trial for Volasertib
Premium
Company Announcements
Notable Labs Advances with Phase 2 Trial for Volasertib
2y ago
8K
NTBL
Notable Labs receives FDA clearance to proceed further with volasertib study
Premium
The Fly
Notable Labs receives FDA clearance to proceed further with volasertib study
2y ago
NTBL
Notable Labs files to sell 19.74M ordinary shares, pre-funded warrants
PremiumThe Fly
Notable Labs files to sell 19.74M ordinary shares, pre-funded warrants
2y ago
NTBL
Notable Labs Unveils Strategic Outlook in Business Update
PremiumCompany Announcements
Notable Labs Unveils Strategic Outlook in Business Update
2y ago
8K
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe Fly
Notable Labs management to meet with Maxim Group
2y ago
NTBL
Notable Labs price target lowered to $5 from $7 at Chardan
PremiumThe Fly
Notable Labs price target lowered to $5 from $7 at Chardan
2y ago
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe FlyNotable Labs management to meet with Maxim Group
2y ago
NTBL
Notable Labs management to meet with Maxim Group
Premium
The Fly
Notable Labs management to meet with Maxim Group
2y ago
NTBL
Notable Labs management to meet with Maxim Group
Premium
The Fly
Notable Labs management to meet with Maxim Group
2y ago
NTBL
Notable Labs Shares Strategic Insights in Business Overview
PremiumCompany Announcements
Notable Labs Shares Strategic Insights in Business Overview
2y ago
8K
NTBL
Notable Labs price target lowered to $7 from $9 at Chardan
PremiumThe Fly
Notable Labs price target lowered to $7 from $9 at Chardan
2y ago
NTBL
Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
PremiumCompany Announcements
Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
2y ago
NTBL
Notable Labs sees cash runway into 4Q24
PremiumThe Fly
Notable Labs sees cash runway into 4Q24
2y ago
NTBL
Notable Labs reports 2023 EPS ($3.41) vs. ($21.97) last year
PremiumThe FlyNotable Labs reports 2023 EPS ($3.41) vs. ($21.97) last year
2y ago
NTBL
Two new option listings and option delistings on March 25th
Premium
The Fly
Two new option listings and option delistings on March 25th
2y ago
AQB
GNS
Notable Labs Advances Phase 2 Trial for Volasertib
Premium
Company Announcements
Notable Labs Advances Phase 2 Trial for Volasertib
2y ago
8K
NTBL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >